Trinity Therapeutics, Inc.
Records under this name other than patents Trinity Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to Trinity Therapeutics, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,362,202 | Methods for inhibiting immune complex formation in a subject Lapsed on the fee record Ended Jan 29, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jan 29, 2025 | From the USPTO record |
| US 9,447,145 | Compositions for inhibiting immune complex formation in a subject Lapsed on the fee record Ended Sep 20, 2024 · From the USPTO record | Lapsed on the fee record | Ended Sep 20, 2024 | From the USPTO record |
| US 7,584,059 | Inhibition of immune complex formation Term ended Term ended Aug 6, 2023 · From the USPTO record | Term ended | Term ended Aug 6, 2023 | From the USPTO record |
| US 6,916,904 | Inhibition of immune complex formation Term ended Term ended Jun 10, 2023 · From the USPTO record | Term ended | Term ended Jun 10, 2023 | From the USPTO record |
| US 10,179,803 | Methods for inhibiting immune complex formation in a subject Lapsed on the fee record Ended Jan 15, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jan 15, 2023 | From the USPTO record |
| US 7,786,258 | Methods for inhibiting immune complex formation in a subject Lapsed on the fee record Ended Aug 31, 2022 · From the USPTO record | Lapsed on the fee record | Ended Aug 31, 2022 | From the USPTO record |
| US 8,815,813 | Methods for Treating Immune-Mediated Dengue Fever Infections and Antibody-Dependent Enhancement of Dengue Fever Infections, Including Dengue Hemorrhagic Fever and Dengue Shock Syndrome Lapsed on the fee record Ended Aug 26, 2022 · High confidence | Lapsed on the fee record | Ended Aug 26, 2022 | High confidence |
| US 7,714,104 | Methods for inhibiting immune complex formation in a subject Lapsed on the fee record Ended May 11, 2022 · From the USPTO record | Lapsed on the fee record | Ended May 11, 2022 | From the USPTO record |